Sulfamethoxazole and trimethoprim double strength vs. Clindamycin phosphate: side effect and effectiveness comparison - a phase IV clinical study
Summary:
We compare the side effects and drug effectiveness of Sulfamethoxazole and trimethoprim double strength and Clindamycin phosphate. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 192,573 people who take Sulfamethoxazole and trimethoprim double strength and Clindamycin phosphate, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
192,573 people who take Sulfamethoxazole and trimethoprim double strength and Clindamycin phosphate are studied.
What is Sulfamethoxazole and trimethoprim double strength?
Sulfamethoxazole and trimethoprim double strength has active ingredients of sulfamethoxazole; trimethoprim. It is often used in urinary tract infection. eHealthMe is studying from 405 Sulfamethoxazole and trimethoprim double strength users for its effectiveness, alternative drugs and more.
What is Clindamycin phosphate?
Clindamycin phosphate has active ingredients of clindamycin phosphate. It is often used in infection. eHealthMe is studying from 3,460 Clindamycin phosphate users for its effectiveness, alternative drugs and more.
Number of reports submitted per year:

Drugs being compared in this study:
- Clindamycin Phosphate (clindamycin phosphate)
- Sulfamethoxazole And Trimethoprim Double Strength (sulfamethoxazole; trimethoprim)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Sulfamethoxazole And Trimethoprim Double Strength:
- not at all: 7.79 %
- somewhat: 25.3 %
- moderate: 27.09 %
- high: 28.09 %
- very high: 11.72 %
Clindamycin Phosphate:
- not at all: 6.32 %
- somewhat: 27.47 %
- moderate: 26.68 %
- high: 28.46 %
- very high: 11.07 %
Want to compare Sulfamethoxazole and trimethoprim double strength with Clindamycin phosphate?
Personalize this study to your gender and age (0-99+).How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related studies
Alternative drugs to, pros and cons of:
- Sulfamethoxazole and trimethoprim double strength (328 reports)
- Clindamycin phosphate (3,111 reports)
Common Clindamycin phosphate side effects:
- Rashes (redness): 317 reports
- Drug ineffective: 283 reports
- Diarrhea: 193 reports
- Fever: 159 reports
- Fatigue (feeling of tiredness): 158 reports
- Pain: 152 reports
- Breathing difficulty: 114 reports
- Pneumonia: 113 reports
Browse all side effects of Clindamycin phosphate:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on sulfamethoxazole; trimethoprim and clindamycin phosphate (the active ingredients of Sulfamethoxazole and trimethoprim double strength and Clindamycin phosphate, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Ceftriaxone Sodium and Eosinophilic Pneumonia - 8 seconds ago
- Ranitidine and Carotid Artery Dissection - 12 seconds ago
- Desyrel and Ramipril drug interaction - 51 seconds ago
- Ritalin La and Dry Eyes - a minute ago
- Trelegy Ellipta and Pneumonia Streptococcal - a minute ago
- Lactulose and Labor Complication - a minute ago
- Fludrocortisone Acetate and High Blood Pressure - a minute ago
- Ventolin Hfa and Retrovir drug interaction - a minute ago
- Menstrual Cycle Management and Panic Disorder - 2 minutes ago
- Empliciti and Hyperglycemia - 2 minutes ago